RxDoctor Payments DataLook up a doctor →

Michael Spezia, DO

Family Medicine · Saint Louis, MONPI 1316928369

Payments from drug & device makers

$26,414in general payments, 2019–2025

Across 1,148 payments — averaging $23.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$6K
  • AbbVie$2K
  • GSK$2K
  • Novo Nordisk$2K
  • Pfizer$2K
  • Otsuka America Pharmaceutical, Inc.$1K
  • plus $12K from 49 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca151$5,952
AbbVie(2 entities)145$2,115
GSK135$1,992
Novo Nordisk80$1,649
Pfizer114$1,528
Otsuka America Pharmaceutical, Inc.51$1,369
Lilly USA, LLC64$1,289
Merck56$1,034
Astellas Pharma US Inc22$641
Novartis36$603
Bayer15$553
Johnson & Johnson13$547
Biohaven Pharmaceutical Holding Company Ltd.20$524
Amarin Pharma, Inc.19$520
Dexcom, Inc.13$447
Biohaven Pharmaceuticals, Inc.8$426
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$370
Nevro Corp.10$366
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)13$356
Sanofi-aventis U.S. LLC10$344
Phathom Pharmaceuticals, Inc.9$341
Boehringer Ingelheim13$329
Aimmune Therapeutics, Inc.11$308
Nestle Healthcare Nutrition Inc.8$267
Exact Sciences8$263
Sunovion Pharmaceuticals Inc.14$213
Kowa Pharmaceuticals America, Inc.5$206
Biosense Webster, Inc.2$197
Melinta Therapeutics, LLC2$146
Gilead3$142
Sumitomo Pharma America, Inc.7$132
SK Life Science, Inc.1$125
VBI Vaccine (delaware) Inc.5$97
Lundbeck LLC5$91
Travere Therapeutics, Inc.1$88
Amgen4$83
Ardelyx, Inc.5$82
Abbott4$76
Globus Medical3$61
Medtronic(2 entities)4$57
Takeda Pharmaceuticals U.S.A., Inc.6$56
Hikma Pharmaceuticals USA3$54
Arbor Pharmaceuticals, Inc.4$51
Paratek Pharmaceuticals, Inc.3$48
Heron Therapeutics, Inc.3$46
Eyevance Pharmaceuticals LLC2$38
Averitas Pharma Inc.1$34
Ironwood Pharmaceuticals, Inc2$34
Lexicon Pharmaceuticals, Inc.1$25
Esperion Therapeutics, Inc.1$21
Xeris Pharmaceuticals, Inc.1$20
Shield Therapeutics Inc1$16
Neurocrine Biosciences, Inc.1$15
Elite Orthopedics, LLC1$13
Vanda Pharmaceuticals Inc.1$13

How this compares

$26,414 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri →

Medicare billing

Part B allowed, 2024
$56,035
Medicare patients
138
Services billed
628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →